Overview

Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prospectively analyze changes in macular pigment optical density and dermal carotenoid levels as they relate to visual field function in patients prescribed a macular pigment-containing medical food (Lumega-Z), in combination with a topical carbonic anhydrase inhibitor.
Phase:
Phase 4
Details
Lead Sponsor:
University of the Incarnate Word
Collaborator:
Guardion Health Sciences, Inc.
Treatments:
Dorzolamide